Literature DB >> 11255424

Reproductive period and risk of dementia in postmenopausal women.

M I Geerlings1, A Ruitenberg, J C Witteman, J C van Swieten, A Hofman, C M van Duijn, M M Breteler, L J Launer.   

Abstract

CONTEXT: Exogenous estrogen use may lower risk of dementia in postmenopausal women. A relationship between long-term exposure to endogenous estrogens and incident dementia has been hypothesized but not studied.
OBJECTIVE: To determine whether a longer reproductive period, as an indicator of longer exposure to endogenous estrogens, is associated with lower risk of dementia and Alzheimer disease (AD) in women who have natural menopause. DESIGN AND
SETTING: The Rotterdam Study, a population-based prospective cohort study conducted in the Netherlands. PARTICIPANTS: A total of 3601 women aged 55 years or older who did not have dementia at baseline (1990-1993) and had information on age at menarche, age at menopause, and type of menopause. Participants were reexamined in 1993-1994 and 1997-1999 and were continuously monitored for development of dementia. MAIN OUTCOME MEASURES: Incidence of dementia, based on Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition criteria, and AD, based on National Institute of Neurological Disorders and Stroke/Alzheimer's Disease and Related Disorders Association criteria, compared by quartiles of reproductive period among women with natural menopause.
RESULTS: During 21 046 person-years of follow-up (median follow-up, 6.3 years), 199 women developed dementia, including 159 who developed AD. After adjusting for age, dementia was not clearly associated with length of reproductive period. However, after adjusting for multiple covariates, women with natural menopause and more reproductive years had an increased risk of dementia (adjusted rate ratio [RR] for women with >39 reproductive years [highest quartile] compared with <34 reproductive years [lowest quartile], 1.78; 95% confidence interval [CI], 1.12-2.84). The adjusted RR per year of increase was 1.04 (95% CI, 1.01-1.08). For risk of AD, the adjusted RRs were 1.51 (95% CI, 0.91-2.50) and 1.03 (95% CI, 1.00-1.07), respectively. Risk of dementia associated with a longer reproductive period was most pronounced in APOE epsilon4 carriers (adjusted RR for >39 reproductive years compared with <34 reproductive years, 4.20 [95% CI, 1.97-8.92] for dementia and 3.42 [95% CI, 1.51-7.75] for AD), whereas in noncarriers, no clear association with dementia or AD was observed.
CONCLUSION: Our findings do not support the hypothesis that a longer reproductive period reduces risk of dementia in women who have natural menopause.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11255424     DOI: 10.1001/jama.285.11.1475

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  39 in total

Review 1.  The role of ovarian hormones in preserving cognition in aging.

Authors:  Jeri S Janowsky
Journal:  Curr Psychiatry Rep       Date:  2002-12       Impact factor: 5.285

2.  Obesity and central obesity as risk factors for incident dementia and its subtypes: a systematic review and meta-analysis.

Authors:  M A Beydoun; H A Beydoun; Y Wang
Journal:  Obes Rev       Date:  2008-03-06       Impact factor: 9.213

Review 3.  Pregnancy, postpartum and parity: Resilience and vulnerability in brain health and disease.

Authors:  Nicholas P Deems; Benedetta Leuner
Journal:  Front Neuroendocrinol       Date:  2020-01-24       Impact factor: 8.606

Review 4.  Estrogenic Endocrine Disrupting Chemicals Influencing NRF1 Regulated Gene Networks in the Development of Complex Human Brain Diseases.

Authors:  Mark Preciados; Changwon Yoo; Deodutta Roy
Journal:  Int J Mol Sci       Date:  2016-12-13       Impact factor: 5.923

5.  Prior endogenous and exogenous estrogen and incident dementia in the 10th decade of life: The 90+ Study.

Authors:  A Paganini-Hill; M M Corrada; C H Kawas
Journal:  Climacteric       Date:  2020-02-28       Impact factor: 3.005

6.  Age at surgical menopause influences cognitive decline and Alzheimer pathology in older women.

Authors:  Riley Bove; Elizabeth Secor; Lori B Chibnik; Lisa L Barnes; Julie A Schneider; David A Bennett; Philip L De Jager
Journal:  Neurology       Date:  2013-12-11       Impact factor: 9.910

Review 7.  Sex and the development of Alzheimer's disease.

Authors:  Christian J Pike
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 8.  Sex differences in cognitive impairment and Alzheimer's disease.

Authors:  Rena Li; Meharvan Singh
Journal:  Front Neuroendocrinol       Date:  2014-01-13       Impact factor: 8.606

Review 9.  Understanding the impact of sex and gender in Alzheimer's disease: A call to action.

Authors:  Rebecca A Nebel; Neelum T Aggarwal; Lisa L Barnes; Aimee Gallagher; Jill M Goldstein; Kejal Kantarci; Monica P Mallampalli; Elizabeth C Mormino; Laura Scott; Wai Haung Yu; Pauline M Maki; Michelle M Mielke
Journal:  Alzheimers Dement       Date:  2018-06-12       Impact factor: 21.566

10.  Reproductive factors and hormone use and risk of adult gliomas.

Authors:  Martha J Felini; Andrew F Olshan; Jane C Schroeder; Susan E Carozza; Rei Miike; Terri Rice; Margaret Wrensch
Journal:  Cancer Causes Control       Date:  2008-09-03       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.